"Benzomorphans" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Morphine derivatives of the methanobenzazocine family that act as potent analgesics.
Descriptor ID |
D001575
|
MeSH Number(s) |
D03.132.577.249.106 D04.615.723.795.106
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Benzomorphans".
Below are MeSH descriptors whose meaning is more specific than "Benzomorphans".
This graph shows the total number of publications written about "Benzomorphans" by people in this website by year, and whether "Benzomorphans" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2000 | 1 | 0 | 1 |
2001 | 2 | 0 | 2 |
2002 | 1 | 0 | 1 |
2004 | 1 | 0 | 1 |
2005 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Benzomorphans" by people in Profiles.
-
Dortch-Carnes J, Potter DE. Bremazocine: a kappa-opioid agonist with potent analgesic and other pharmacologic properties. CNS Drug Rev. 2005; 11(2):195-212.
-
Potter DE, Russell KR, Manhiani M. Bremazocine increases C-type natriuretic peptide levels in aqueous humor and enhances outflow facility. J Pharmacol Exp Ther. 2004 May; 309(2):548-53.
-
Dortch-Carnes J, Potter DE. Effect of bremazocine, a kappa-opioid receptor agonist, on inositol phosphate formation in isolated iris-ciliary bodies. Pharmacology. 2002 Oct; 66(2):100-6.
-
Russell KR, Moore TT, Potter DE. Elevation of atrial natriuretic peptide levels in aqueous humor of the rabbit by kappa opioid receptor agonists. Neuropeptides. 2001 Oct-Dec; 35(5-6):232-7.
-
Russell KR, Potter DE. Biphasic alterations of cAMP levels and inhibition of norepinephrine release in iris-ciliary body by bremazocine. J Pharmacol Exp Ther. 2001 Sep; 298(3):941-6.
-
Russell KR, Wang DR, Potter DE. Modulation of ocular hydrodynamics and iris function by bremazocine, a kappa opioid receptor agonist. Exp Eye Res. 2000 May; 70(5):675-82.